YahooOctober 26, 2026 at 4:01 PM NYYesterday
Definium Therapeutics Announces New Employee Inducement Grants
NEW YORK, October 26, 2026--Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to six newly hired non-executive employees consisting of options to purchase an aggregate of 93,320 common shares of the Company (the "Options") with effective grant dates of October 26, 202
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
